NTRK1 and neoplasm: The effect of antiangiogenic therapy on the established parameters of the microscopic tumor vasculature was tested with two agents: the receptor-tyrosine kinase inhibitor axitinib and the VEGF-A sequestering antibody mG6-31 [30].